Fintel reports that on December 15, 2025, Truist Securities initiated coverage of Septerna (NasdaqGM:SEPN) with a Buy ...
Truist initiated coverage of Septerna (SEPN) with a Buy rating and $34 price target The firm says the company’s SEP-631 is in Phase 1 for chronic ...